Biorasi’s podcast – Few & Far Between: Conversations About Rare Disease Research – was created to engage in discussions on trending topics and innovations in rare and urgent disease clinical research. Hosted by Chris O’Brien, CEO, each monthly episode features conversations between Biorasi leaders and rare disease industry experts.
Our latest episodes can be found here.
- Episode 29: Mika Newton, CEO at XCures
- Episode 28: Dr. Alok Tayi, Founder and CEO of VibeBio
- Episode 27, Part 2: Jamie Heywood, Biotech Engineer and Entrepreneur
- Episode 27, Part 1: Jamie Heywood, Biotech Engineer and Entrepreneur
- Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.
- Episode 25: Jim Geraghty, Author and Biotech Industry Veteran
- Episode 25: Jim Geraghty, Author and Biotech Industry Veteran
- Episode 24: Gadi Lachman, President and CEO, TriNetX
- Episode 23: Dr. Arun Bhatt, Consultant for Clinical Research and Drug Development in India
- Episode 23: Dr. Arun Bhatt, Consultant for Clinical Research and Drug Development in India
- Episode 22: Dr. Jocelynn Pearl, Senior Scientist at Tune Therapeutics, Host of Lady Scientist Podcast
- Episode 21: Jill Hawkins, Founder and President of the FAM177A1 Research Fund
- Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.
- Episode 19: Leslie Michelson, Founder and CEO, Private Health Management
- Episode 19: Leslie Michelson, Founder and CEO, Private Health Management
- Episode 18: Karen Petrou and David Brint – BioBonds
- Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)
- Episode 16: Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi
- Episode 15: Dr. Terry Jo Bichell, Founder and Director of COMBINEDBrain
- Episode 15: Dr. Terry Jo Bichell, Founder and Director of COMBINEDBrain
- Episode 14: Bo Bigelow, Chairman at the Foundation for USP7-Related Diseases, and Trish Flanagan, President at the Yellow Brick Road Project
- Episode 13: Kelly Franchetti RN, SVP, Global Head Patient Insights and Strategy at YPrime
- Episode 12: Effie Parks and Spela Mirosevic
- Episode 12: Effie Parks and Spela Mirosevic
- Episode 11: Rebecca Stewart and Nicola Miller from Rare Revolution Magazine
- Episode 10: Sharon Terry, CEO Genetic Alliance
- Episode 9: Zogenix, Inc.'s Dawn Blessing and J. Michael Graglia from SynGAP
- Episode 8: David Rose, Rare Disease Speaker and Advocate
- Episode 7: US Congressman Gus Bilirakis
- Episode 7: US Congressman Gus Bilirakis
- Episode 6: Dr. Mehool Patel and Dr. Dilhan Weeraratne, IBM Watson Health
- Episode 6: Dr. Mehool Patel and Dr. Dilhan Weeraratne, IBM Watson Health
- Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc
- Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc
- Episode 4: Marianne Clancy, Executive Director at Cure HHT
- Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research
- Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research
- Episode 2: Julie Walters, Founder and Executive Director of Xperiome/Raremark
- Episode 2: Julie Walters, Founder and Executive Director of Xperiome/Raremark
- Episode 1: Paula Evans, CEO and Co-Founder of GeneTx Biotherapeutics
- Episode 1: Paula Evans, CEO and Co-Founder of GeneTx Biotherapeutics
- Episode 0: Welcome to the Few & Far Between Podcast
- Episode 0: Welcome to the Few & Far Between Podcast
